# Trade Mark Journal No.2026/016 17 April 2026

## WO0000001911288 (40,42)

Office of origin: Republic of Korea

Date of International Registration:5 February 2026
Date of designation in the UK: 5 February 2026

Class 40
  Custom manufacture of biopharmaceuticals; processing of biopharmaceutical materials for others; treatment of biopharmaceutical materials; custom manufacture of cell lines for manufacturing biopharmaceuticals; chemical treatment of liquids; processing of medicinal materials; custom manufacture of pharmaceuticals; processing of pharmaceutical preparations; preservation of pharmaceuticals; custom manufacture of specific antibody-binding glycosylation drugs; processing of chemicals.
Class 42
  High-efficiency scientific laboratory service for glycan analysis; culturing of cells for scientific research purposes; scientific research; biological research and analysis relating to glycosylation profiles; multiple nucleic acid analysis; protein analysis; toxicity analysis; analysis in the field of molecular biology; development of biotechnology; biotechnological research; biological analysis; biological research; research of biologics; biochemical analysis; biochemical research; food research; conducting early evaluations in the field of new pharmaceuticals; drug discovery services; development of pharmaceutical preparations and medicines; pharmaceutical research and development; research on the subject of pharmaceuticals; pharmaceutical product evaluation; clinical research in the field of medicine; services for assessing the efficiency of pharmaceuticals; scientific research in the field of genetics and genetic engineering; genetic research; computer programming in the medical field; medical laboratories; maintenance and consulting services related to software used for management support services for medical image data; medicine research; analysis and evaluation of medical product development; providing information on the testing, inspection and research of medical products; evaluating of clinical trial progress; clinical trials.

Samsung Biologics Co. , Ltd.

Representative: HANOL Intellectual Property & Law, 6th Floor, 135, Beobwon-Ro, Songpa-Gu, Seoul 05836, REPUBLIC OF KOREA